Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Iterum Therapeutics plc | Chief Executive Officer, Director | Ordinary Shares | 137K | $192K | $1.40 | Aug 6, 2024 | Direct |
Iterum Therapeutics plc | Chief Executive Officer, Director | Warrants (right to buy) | 82.6K | Aug 6, 2024 | Direct | ||
Iterum Therapeutics plc | Chief Executive Officer, Director | Subscription Rights (right to buy) | 0 | Aug 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ITRM | Iterum Therapeutics plc | Aug 6, 2024 | 4 | $0 | 4 | Aug 12, 2024 | Chief Executive Officer, Director |
ITRM | Iterum Therapeutics plc | Nov 20, 2023 | 1 | $15.9K | 4 | Nov 20, 2023 | Chief Executive Officer, Director |
ITRM | Iterum Therapeutics plc | Mar 31, 2023 | 1 | $0 | 4 | Apr 3, 2023 | Chief Executive Officer, Director |
ITRM | Iterum Therapeutics plc | Mar 11, 2023 | 3 | -$5.46K | 4 | Mar 14, 2023 | Chief Executive Officer, Director |
ITRM | Iterum Therapeutics plc | Mar 11, 2022 | 2 | $0 | 4 | Mar 15, 2022 | Chief Executive Officer, Director |
ITRM | Iterum Therapeutics plc | Jun 23, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Chief Executive Officer, Director |